Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms
Recruiting
N/A
Interventional Study
Aneurysm
Brain Aneurysm
Congenital Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 1,100 (estimated)
- Sponsor
- Nantes University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the bCAN study is to create a prospective collection of multimodal data and human samples, linked to the French Intracranial Aneurysm Registry (FRAN).
The aim of bCAN is to enable risk stratification of ruptured ICAs by redefining "intracranial aneurysm disease". The description of genotypically and phenotypically specific subgroups of cases will pave the way for improved patient m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria for sporadic ICA cases:
* Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography
* Aneurysm discovered less than a year ago, with initial imaging (MRI and/or CTA and DSA) available
* Written consent obtained for …
Contacts